[Experience with the use of parlodel in the treatment of Parkinson patients].
The dopamine agonist parlodel was given to 42 patients with parkinsonism for several months. The drug proved effective in more than one-third of the patients. Different side-effects were observed in almost half of the patients. Parlodel may be used alone in mild cases but generally it is used as an adjunct to L-DOPA therapy. The optimum dose of parlodel is individual and varies within a wide range.
Stoliarova
L G
LG
Kadykov
A S
AS
Shvedkov
V V
VV
Pivovarova
V M
VM
D000328:Adult; D000368:Aged; D001971:Bromocriptine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D002534:Hypoxia, Brain / Q000150:complications; D007980:Levodopa / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D010301:Parkinson Disease, Postencephalitic / Q000188:drug therapy; D010302:Parkinson Disease, Secondary / Q000188:drug therapy
D001971:Bromocriptine; D007980:Levodopa
Opyt primeneniia parlodela pri lechenii bol'nykh parkinsonizmom.